Advaxis Inc. (NASDAQ:ADXS) shares fell to a low of $1.07 before closing at $1.07. Intraday shares traded counted 10.0 million, which was 32.95% higher than its 30-day average trading volume of 14.92M. ADXS’s previous close was $1.17 while the outstanding shares total 108.74M. The firm has a beta of 3.06. The stock’s Relative Strength Index (RSI) is 57.46, with weekly volatility at 18.20% and ATR at 0.14. The ADXS stock’s 52-week price range has touched low of $0.26 and a $1.57 high. The stock traded lower over the last trading session, losing -8.55% on 02/22/21.
Investors have identified the Biotechnology company Advaxis Inc. as an interesting stock but before investments are made there, an in-depth look at its trading activities will have to be conducted. The share is trading with a market value of around $122.91 million, the company now has both obstacles and catalysts that affect them and they came from their mode of operations. With the company affected by events currently, it is a perfect time to analyze the numbers behind the firm in order to come up with a rather realistic picture of what this stock is.
Advaxis Inc. (ADXS) Fundamentals that are to be considered.
When analyzing a stock, the first fundamental thing to take into account is the balance sheet. How healthy the balance sheet of a company is will determine if the company will be able to carry out all its financial and non-financial obligations and also keep the faith of its investors. In terms of their assets, the company currently has 27.85 million total, with 3.29 million as their total liabilities.
Is the stock of ADXS attractive?
In related news, Director, APPEL RONI sold 2,401 shares of the company’s stock in a transaction that recorded on Mar 13. The sale was performed at an average price of 0.55, for a total value of 1,321. As the sale deal closes, the Director, APPEL RONI now sold 200 shares of the company’s stock, valued at 116. Also, Director, APPEL RONI sold 399 shares of the company’s stock in a deal that was recorded on Mar 11. The shares were price at an average price of 0.67 per share, with a total market value of 267. In the last 6 months, insiders have changed their ownership in shares of company stock by 0.09%.